rs11190141

This is a regulatory region variant variant in the NKX2-3 gene.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

monocyte count

Allele T
OR
p 2.0e-116
N 639,696
Large GWAS
multi-ancestry
Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele T
OR 0.04
p 9.0e-69
N 444,975
Large GWAS
multi-ancestry
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele T
OR 0.04
p 2.0e-55
N 408,112
Large GWAS
European
Allele T
OR 0.04
p 4.0e-82
N 394,642
Large GWAS
European
Kachuri L et al. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia. American Journal of Human Genetics 108(10):1823-1835 (2021)
Allele T
OR
p 7.0e-36
N 234,690
Large GWAS
European
Allele T
OR 0.05
p 3.0e-36
N 170,721
Large GWAS
European
Allele T
OR 0.04
p 6.0e-11
N 38,000
Large GWAS
South Asian

monocyte percentage of leukocytes

Allele T
OR 0.03
p 6.0e-65
N 394,642
Large GWAS
European
Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele T
OR 0.04
p 3.0e-61
N 408,112
Large GWAS
European
Allele T
OR 0.04
p 2.0e-25
N 170,494
Large GWAS
European

granulocyte percentage of myeloid white cells

Allele T
OR 0.03
p 4.0e-19
N 169,545
Large GWAS
European

lymphocyte count

Allele T
OR
p 2.0e-10
N 643,370
Large GWAS
multi-ancestry

About NKX2-3

This gene encodes a homeodomain-containing transcription factor. The encoded protein is a member of the NKX family of homeodomain transcription factors. Studies of similar proteins in mouse and rat have indicated a potential role in cellular differentiation.[provided by RefSeq, Mar 2010]

View all NKX2-3 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…